Inventor · disambiguated record
Scott W. Bagley
Also filed as: BAGLEY SCOTT · BAGLEY SCOTT W · BAGLEY SCOTT WILLIAM
28 granted patents·14 pending applications·406 citations·filing 1991–2025
97Inventor score
Top patents by PatentIndex Score
42 records- 0198US10851081B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Dec 1, 2020·12 cites·19 claims
- 0297US11512070B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Nov 29, 2022·11 cites·16 claims
- 0397US10208019B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2017·Granted Feb 19, 2019·50 cites·26 claims
- 0496US10934279B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Mar 2, 2021·9 cites·16 claims
- 0596US10683281B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jun 16, 2020·8 cites·30 claims
- 0696US10676465B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jun 9, 2020·8 cites·30 claims
- 0795US5334598ASix-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1993·Granted Aug 2, 1994·101 cites·8 claims
- 0894US12378230B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Aug 5, 2025·1 cites·20 claims
- 0994US10669259B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2018·Granted Jun 2, 2020·13 cites·31 claims
- 1091US8288405B2N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitorsBAGLEY SCOTT WILLIAM·Filed 2010·Granted Oct 16, 2012·23 cites·19 claims
- 1191US5668176APhenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1996·Granted Sep 16, 1997·59 cites·14 claims
- 1290US8507681B2N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2012·Granted Aug 13, 2013·10 cites·8 claims
- 1388US12319669B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 3, 2025·0 cites·21 claims
- 1487US5565485ABiphenyl compounds useful or endothelin antagonistsMERCK & CO INC·Filed 1994·Granted Oct 15, 1996·32 cites·23 claims
- 1587US2025340544A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2025·Application pending·0 cites
- 1686US11858916B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jan 2, 2024·2 cites·20 claims
- 1783US11661419B2Benzimidazole derivative compounds and uses thereofPFIZER·Filed 2020·Granted May 30, 2023·1 cites·23 claims
- 1883US2025257052A1Glp-1 receptor agonists and uses thereofPFIZER·Filed 2025·Application pending·0 cites
- 1982US11802121B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2022·Granted Oct 31, 2023·0 cites·20 claims
- 2081US12331041B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 2181US8802690B2N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2013·Granted Aug 12, 2014·3 cites·4 claims
- 2277US2025270196A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2025·Application pending·0 cites
- 2373US5151435AAngiotensin ii antagonists incorporating an indole or dihydroindoleMERCK & CO INC·Filed 1991·Granted Sep 29, 1992·30 cites·10 claims
- 2472US2021163455A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 2571US8859773B2N1/N2-lactam acetyl-CoA carboxylase inhibitorsGRIFFITH DAVID A·Filed 2011·Granted Oct 14, 2014·2 cites·3 claims
- 2665US9139587B2N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2014·Granted Sep 22, 2015·0 cites·5 claims
- 2765US5401745AQuinazolinones substituted with phenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1993·Granted Mar 28, 1995·10 cites·10 claims
- 2864US8993586B2N1/N2-lactam acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2014·Granted Mar 31, 2015·0 cites·3 claims
- 2963US5767310APhenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1994·Granted Jun 16, 1998·8 cites·3 claims
- 3062US2023280220A1Benzimidazole Derivative Compounds and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 3161US2024109915A1Novel acc inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 3260US7199243B2Piperidine compounds useful as PPAR activatorsPFIZER PROD INC·Filed 2003·Granted Apr 3, 2007·2 cites·12 claims
- 3357US2024124439A1Pyrido[2,3-D]Imidazole Derivatives and Their Use As Inhibitors of ITK for the Treatment of Skin DiseasePFIZER·Filed 2021·Application pending·0 cites
- 3457US2024132477A1Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin DiseasePFIZER·Filed 2021·Application pending·0 cites
- 3554US9181252B2N1/N2-lactam acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2015·Granted Nov 10, 2015·0 cites·6 claims
- 3654US5175164AAngiotensin ii antagonists incorporating a substituted indole or dihydroindoleMERCK & CO INC·Filed 1991·Granted Dec 29, 1992·11 cites·12 claims
- 3754US2025129057A1Solid Forms of 2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine SaltPFIZER·Filed 2022·Application pending·0 cites
- 3852US2016358284A1Computerized system and method for coding medical recordsBAGLEY SCOTT·Filed 2011·Application pending·0 cites
- 3950US2022387402A1Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseasesPFIZER·Filed 2020·Application pending·0 cites
- 4049US2007191429A1Ppar activatorsPFIZER·Filed 2007·Application pending·0 cites
- 4145US2023045419A1Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine SaltPFIZER·Filed 2020·Application pending·0 cites
- 4235US2012225900A1N2-pyrazolospiroketone acetyl-coa carboxylase inhibitorsBAGLEY SCOTT WILLIAM·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott W. Bagley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →